Conclusion: This NMA shows heterogeneous effects of nutraceuticals on obesity-related outcomes
And of those who said no, the feeling was strongest among diabetic users (15%), versus 5% for weight-loss users
Experimental research has reported increases in angiogenesis ranging from 129% to 152%
Wegovy (semaglutide) is a GLP-1 medication that helps with weight loss by reducing appetite, increasing fullness, and lowering food noise. Until recently, Wegovy was best known as a weekly injection
Recent investigations from 2023 to 2025 highlight several key findings: microneedle-based delivery consistently reduced neuropathic pain [94], improved nerve function through precise local drug application [95], promoted regeneration when combined with stem cellderived products or electrically responsive systems [96], and decreased inflammation when loaded with anti-inflammatory agents [97]
And the Pioneer tool confirms or demonstrates what the out of pocket cost increases have been in real time
